Point72 Europe’s Gilead Sciences GILD Stock Holding History

Point72 Europe’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-125,624	Closed	-$13.9M	–	755
2025 Q2	$13.9M	Buy	125,624 +40,924	+48%	+$4.36M	0.54%	47
2025 Q1	$9.49M	Buy	84,700 +14,206	+20%	+$1.47M	0.65%	60
2024 Q4	$6.51M	Sell	70,494 -34,903	-33%	-$3.14M	0.38%	68
2024 Q3	$8.84M	Buy	105,397 +9,702	+10%	+$740K	0.56%	51
2024 Q2	$6.57M	Buy	+95,695	New	+$6.39M	0.54%	61
2024 Q1	–	Sell	-35,490	Closed	-$2.88M	–	239
2023 Q4	$2.88M	Buy	+35,490	New	+$2.76M	0.36%	62

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Europe's GILD Position: Q3 2025 in Review

Point72 Europe sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 125,624 shares — an estimated $13.9M sold.

Point72 Europe first reported a position in GILD in Q4 2023 and held it in 6 quarters. The position peaked at $13.9M in Q2 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Point72 Europe reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Point72 Europe sold 125,624 Gilead Sciences shares in Q3 2025, an estimated $13.9M.
Point72 Europe first reported a position in Gilead Sciences in Q4 2023 and held it in 6 quarters.
Point72 Europe's Gilead Sciences position peaked at $13.9M in Q2 2025.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.